Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Bionik Laboratories's share price for the quarter that ended in Mar. 2023 was $0.4. Bionik Laboratories's Shares Outstanding (EOP) for the quarter that ended in Mar. 2023 was 6.88 Mil. Therefore, Bionik Laboratories's market cap for the quarter that ended in Mar. 2023 was $2.75 Mil.
Bionik Laboratories's quarterly market cap
increased
from Sep. 2022 ($2.04 Mil) to Dec. 2022 ($4.21 Mil) but then
declined
from Dec. 2022 ($4.21 Mil) to Mar. 2023 ($2.75 Mil).
Bionik Laboratories's annual market cap
declined
from Mar. 2021 ($13.97 Mil) to Mar. 2022 ($2.54 Mil) but then
increased
from Mar. 2022 ($2.54 Mil) to Mar. 2023 ($2.75 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Bionik Laboratories's Enterprise Value for Today is $3.23 Mil.
Bionik Laboratories Market Cap Historical Data
The historical data trend for Bionik Laboratories's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Bionik Laboratories's Market Cap
For the Medical Care Facilities subindustry, Bionik Laboratories's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bionik Laboratories's Market Cap Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Bionik Laboratories's Market Cap distribution charts can be found below:
* The bar in red indicates where Bionik Laboratories's Market Cap falls into.
Bionik Laboratories Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Bionik Laboratories's Market Cap for the fiscal year that ended in Mar. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bionik Laboratories (OTCPK:BNKL) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Bionik Laboratories Market Cap Related Terms
Thank you for viewing the detailed overview of Bionik Laboratories's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Bionik Laboratories (Bionik Laboratories) Business Description
Bionik Laboratories Corp is a healthcare company focused on improving the quality of life of millions of people with neurological or mobility impairments by combining artificial intelligence and innovative robotics technology to help individuals from hospital to home regain mobility, enhance autonomy, and regain self-esteem. The company uses artificial intelligence and machine learning technologies to make rehabilitation methods and processes smarter and more intuitive to deliver a greater recovery for patients with neurological or mobility impairments. Its products The InMotion ARM, and InMotion ARM/HAND are robotic therapies for the upper limbs.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BNKL has been successfully added to your 